Leaderboards/Adrenal and Paraganglionic Tumors

Adrenal and Paraganglionic Tumors

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Otilia Kimpel
Universitätsklinikum Würzburg
2
Alessa Fischer
University Hospital of Zurich
3
Bruna Calsina
Spanish National Cancer Research Centre
4
Albin Kjellbom
Lund University
5
Abdul Rahman Al Subhi
University of Auckland
6
Aidan Flynn
The University of Melbourne
7
Maria Riedmeier
Universitätsklinikum Würzburg
8
Donatella Treppiedi
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
9
Andreas Ebbehøj
Aarhus University Hospital
10
Stéfanie Parisien‐La Salle
Brigham and Women's Hospital

Papers

1
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma
Hormone and Metabolic Research|2024
16 cit.
2
The Value of Local Therapies in Advanced Adrenocortical Carcinoma
Cancers|2024
14 cit.
3
Publication in European Journal of Endocrinology (2024) [13 citations, W4393347628]
European Journal of Endocrinology|2024
13 cit.
4
Publication in The Journal of Clinical Endocrinology & Metabolism (2025) [13 citations, W4408142045]
The Journal of Clinical Endocrinology & Metabolism|2025
13 cit.
5
Publication in European Journal of Endocrinology (2024) [10 citations, W4400036026]
European Journal of Endocrinology|2024
10 cit.
6
18F-FDG PET/CT for Detection of Immunotherapy-Induced Hypophysitis—A Case-Control Study
Clinical Nuclear Medicine|2024
9 cit.
7
Publication in Journal of the Endocrine Society (2024) [5 citations, W4391163314]
Journal of the Endocrine Society|2024
5 cit.
8
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells
Frontiers in Endocrinology|2025
5 cit.
9
Publication in JACC Basic to Translational Science (2026) [5 citations, W7139960022]
JACC Basic to Translational Science|2026
5 cit.
10
Publication in Pediatric Hematology Oncology Journal (2024) [3 citations, W4392660360]
Pediatric Hematology Oncology Journal|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Irina Bancos
Mayo Clinic in Arizona
2
Katherine Tarvin
National Institutes of Health
3
Erin Curley
Christiana Care Health System
4
Cindy Hochstetler
National Comprehensive Cancer Network
5
Griselda Zuccarino-Catania
Pancreatic Cancer Action Network
6
Satoru Yamakawa
Daiichi Sankyo (Germany)
7
Lauren Fishbein
University of Colorado Cancer Center
8
Luis Jaime Castro‐Vega
Centre National de la Recherche Scientifique
9
Katja Kiseljak‐Vassiliades
Johns Hopkins University
10
Mabel Ryder
Mayo Clinic in Arizona

Papers

1
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023
Journal of the National Comprehensive Cancer Network|2023
206 cit.
2
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Journal of the National Comprehensive Cancer Network|2022
125 cit.
3
Adrenal Insufficiency in Adults
JAMA|2025
43 cit.
4
High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment
European Journal of Endocrinology|2023
33 cit.
5
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network|2025
30 cit.
6
Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States
The Journal of Clinical Endocrinology & Metabolism|2022
28 cit.
7
Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
Thyroid|2023
28 cit.
8
Clinical course and imaging characteristics of benign adrenal cysts: a single-center study of 92 patients
European Journal of Endocrinology|2022
27 cit.
9
Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study
European Journal of Endocrinology|2023
27 cit.
10
Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results From a Multicenter Study
The Journal of Clinical Endocrinology & Metabolism|2022
26 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
William F. Young
Mayo Clinic in Arizona
2
Karel Pacák
Endocrine Society
3
Karel Pacák
Unknown
4
Anne‐Paule Gimenez‐Roqueplo
Délégation Paris 5
5
Massimo Terzolo
University of Turin
6
Jérôme Bertherat
Centre National de la Recherche Scientifique
7
Martin Faßnacht
University of Würzburg
8
Charis Eng
Cleveland Clinic
9
Gary D. Hammer
University of Michigan
10
Mercedes Robledo
Spanish National Cancer Research Centre

Papers

1
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism|2016
2.9k cit.
2
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism|2014
2.8k cit.
3
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
European Journal of Endocrinology|2016
1.5k cit.
4
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
New England Journal of Medicine|2002
1.4k cit.
5
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
JAMA|1996
1k cit.
6
Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents
The Journal of Clinical Endocrinology & Metabolism|2004
955 cit.
7
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
The Lancet Diabetes & Endocrinology|2017
945 cit.
8
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
European Journal of Endocrinology|2018
941 cit.
9
Adrenocortical Carcinoma
Endocrine Reviews|2013
887 cit.
10
Lifetime Cancer Risks in Individuals with Germline<i>PTEN</i>Mutations
Clinical Cancer Research|2012
882 cit.

Reagents for Adrenal and Paraganglionic Tumors

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/Dako

Luteinizing Hormone (LH)

Cited in 6 papers
#M3502
View Evidence →
Agilent/Dako

Follicle-Stimulating Hormone (FSH)

Cited in 6 papers
#M3504
View Evidence →
Agilent/Dako

Polyclonal Rabbit Anti-Human Prolactin

Cited in 6 papers
#A0569
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Polyclonal Rabbit Anti-Human Growth Hormone (hGH)

Cited in 9 papers
#A0570
View Evidence →
Cell Signaling TechnologyEvidence 65

Ret (E1N9A) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 7 papers
#68897$465
View Evidence →
Agilent/Dako

Adrenocorticotropin (ACTH)

Cited in 6 papers
#M3501
View Evidence →